The Future Laboratory Data® (FLD) system by our company has been installed and is now operational in the new headquarters of the Institute for Quantitative Biosciences (IQB) at the University of Tokyo.
FLD is an unprecedented non-contact, non-invasive biomarker measurement device capable of simultaneously measuring Hemoglobin A1c (HbA1c), oxygen saturation, and pulse in a short period (approximately 10 seconds).
The smartphone application FLD HbA1c, which utilizes FLD technology, has been released starting in late September 2025. Furthermore, starting on October 22, 2025, the release has begun in seven countries across Southeast and Southwestern Asia.
We will sequentially disclose further details concerning the joint project with the Institute for Quantitative Biosciences at the University of Tokyo, upon obtaining consent from all relevant parties.